Loading organizations...
§ Private Profile · Pariser Platz 6a, D-10117 Berlin, Germany
AI-pharmacy platform providing digital therapeutics via mobile apps for patients with health conditions.
CURE is a digital health technology company operating an artificial intelligence-driven pharmacy platform that consolidates various healthcare services into a single mobile application. The organization functions as a comprehensive healthcare hub, delivering digital therapeutics and specialized medical solutions directly to consumers through its centralized software ecosystem. Specifically, the enterprise develops and distributes targeted therapeutic applications designed to assist patients in managing chronic medical conditions, with a primary focus on treating hypertension and addressing severe nicotine addiction. By integrating these specialized treatment protocols into a unified digital interface, the platform streamlines patient access to essential pharmacy services and ongoing therapeutic interventions without requiring multiple disparate consumer applications. Operating within the broader digital health sector, the company was established by co-founders Manuel Aberle and Ali El-Ali, with El-Ali currently serving as the organization's chief executive officer.
CURE: One app, all things health has raised $15.0M across 1 funding round.
CURE: One app, all things health has raised $15.0M in total across 1 funding round.
CURE: One app, all things health has raised $15.0M across 1 funding round. Most recently, it raised $15.0M Series A in September 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Sep 1, 2022 | $15M Series A | — | Breega, J12 Ventures, Lakestar, LocalGlobe, Roosh Ventures | Announced |
CURE: One app, all things health has raised $15.0M in total across 1 funding round.
CURE: One app, all things health's investors include Breega, J12 Ventures, Lakestar, LocalGlobe, Roosh Ventures.
Cure is a premier healthcare innovation ecosystem and technology company headquartered in New York City, focused on accelerating medical cures by supporting health innovators in developing groundbreaking products and services from concept to commercialization[1][4]. It operates as an innovation campus offering state-of-the-art research and business facilities, wet and dry labs, office space, and a digital ecosystem that provides mentorship, networking, and business services to startups and established companies in healthcare[1][4][5]. Cure serves health innovators, entrepreneurs, and companies working on diagnostics, devices, drug discovery, care delivery, and public health, addressing the challenge of translating scientific breakthroughs into accessible, effective healthcare solutions[1][5]. The ecosystem has demonstrated strong growth momentum, housing over 20 companies that collectively raised more than $760 million since 2021[5].
Founded as an affiliate of Deerfield, a healthcare investment firm, Cure emerged to create a dedicated innovation hub in NYC that bridges scientific research and commercialization in healthcare[1]. Its leadership, including CEO Seema Kumar, has focused on building a collaborative community that supports health innovators through resources, events, and workspace tailored to the healthcare sector[4][5]. The idea grew from the need to accelerate healthcare innovation by providing an integrated environment combining scientific labs, business infrastructure, and expert networks, enabling startups and enterprises to overcome traditional barriers in healthcare development and scaling[1][4]. Early traction includes hosting flagship events, launching innovation challenges like the Cure Xchange Challenge focused on AI in health, and establishing a vibrant resident community of startups and established companies[5].
Cure rides the wave of rapid healthcare innovation driven by advances in AI, machine learning, and biotechnology, which are reshaping diagnostics, drug development, and care delivery[5][6]. The timing is critical as healthcare systems globally face pressure to improve outcomes, reduce costs, and expand access, creating strong market demand for innovative solutions[6]. Cure’s ecosystem facilitates the translation of scientific discoveries into practical applications by providing infrastructure and community support that accelerates commercialization. It influences the broader ecosystem by convening leaders across academia, industry, government, and investment, fostering cross-sector collaboration and driving forward the future of healthcare innovation[1][4][5].
Looking ahead, Cure is poised to deepen its impact by expanding its resident community, enhancing its digital platform, and continuing to catalyze innovation through targeted challenges and partnerships[5]. Trends such as AI-driven healthcare, personalized medicine, and digital health will shape its trajectory, positioning Cure as a critical launchpad for next-generation health technologies. Its influence is likely to grow as it helps startups navigate regulatory, scientific, and market complexities, ultimately accelerating the delivery of transformative cures and care solutions worldwide[6]. Cure’s integrated model and strategic focus on emerging technologies ensure it remains at the forefront of healthcare innovation ecosystems.